NSBP1 seems to also be associated with CIS resistance in ESCC because knockdown of NSBP1 markedly decreased CIS sensitivity and overexpression of NSBP1 markedly increased CIS resistance [30]. Here, HMGN5 is linked to in situ carcinoma.